The effects of single‐dose dexamethasone on inflammatory response and pain after uterine artery embolisation for symptomatic fibroids or adenomyosis: a randomised controlled study
- 15 December 2015
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 123 (4) , 580-587
Abstract
Objective: To investigate the effects of single‐dose intravenous dexamethasone on inflammatory responses, pain, nausea, and vomiting after uterine artery embolisation (UAE).Design: Prospective, randomised, double‐blind, and placebo‐controlled study.Setting: Tertiary‐care University centre in Korea.Population: Patients undergoing UAE for the treatment of symptomatic fibroids or adenomyosis.Methods: Patients were randomised to receive either intravenous dexamethasone (10 mg; dexamethasone group) or normal saline (control group) 1 hour before UAE. Both groups received fentanyl‐based intravenous patient‐controlled analgesia (PCA) during the 24 hours after UAE.Main outcome measures: The primary outcomes were the inflammatory and stress responses measured by white blood cell count, neutrophil percentage, C–reactive protein (CRP), interleukin–6 (IL–6), and cortisol. Secondary outcomes were severity of pain and incidence of nausea and vomiting.Results: Sixty‐four patients were enrolled and 59 patients completed the study. CRP, IL–6, and cortisol were significantly lower in the dexamethasone group compared with the control group during the 24 hours after UAE. Although the cumulative dose of fentanyl and additional analgesics administered during the 24 hours after UAE were similar between the two groups, pain scores were significantly lower in the dexamethasone group from 12 hours after UAE, and the incidence of severe nausea and vomiting was lower in the dexamethasone group.Conclusions: The administration of single‐dose intravenous dexamethasone as an adjunct to fentanyl‐based intravenous PCA is effective in reducing inflammation and pain during the first 24 hours after UAE.Tweetable Dexamethasone is effective in reducing inflammation and pain after uterine artery embolisation.Keywords
This publication has 26 references indexed in Scilit:
- Perioperative glucocorticoids in hip and knee surgery – benefit vs. harm? A review of randomized clinical trialsActa Anaesthesiologica Scandinavica, 2013
- Basic and Clinical Pharmacology of GlucocorticosteroidsAnesthesia Progress, 2013
- Current Concepts in Uterine Fibroid EmbolizationRadioGraphics, 2012
- Uterine Artery Embolization for the Treatment of Adenomyosis: A ReviewJournal of Vascular and Interventional Radiology, 2011
- Inflammatory response in patients undergoing uterine artery embolization as compared to patients undergoing conventional hysterectomyActa Radiologica, 2009
- Postembolization Syndrome: Changes in White Blood Cell Counts Immediately after Uterine Artery EmbolizationJournal of Vascular and Interventional Radiology, 2008
- Markers of muscle ischemia, necrosis, and inflammation following uterine artery embolization in the treatment of symptomatic uterine fibroidsAmerican Journal of Obstetrics and Gynecology, 2007
- Long‐term follow up of uterine artery embolisation—an effective alternative in the treatment of fibroidsBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- Reporting Standards for Uterine Artery Embolization for the Treatment of Uterine LeiomyomataJournal of Vascular and Interventional Radiology, 2003
- Entwicklung der Entzündungsparameter nach MyomembolisationRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2003